These Analysts Cut Their Forecasts On Inspire Medical Systems Following Q3 Results
1. INSP reported Q3 EPS of 38 cents, exceeding expectations. 2. Sales of $224.501M surpassed analyst projections of $220.467M. 3. FY2025 EPS guidance raised significantly to $0.90-$1.00. 4. Stock price jumped 17% to $86.46 post-announcement. 5. Analysts updated price targets following earnings results.